Research Article| Volume 46, ISSUE 3, SUPPLEMENT 1, 41-46, September 1995

Download started.


Worldwide patterns of prevalence and mortality from benign prostatig hyperplasia

      This paper is only available as a PDF. To read, Please Download here.
      Benign prostatic hyperplasia (BPH) can be found in 88% of autopsies in men ≥80 years, with compatible symptomatology reported in nearly 50% of men aged ≥50 years in the general population. Despite such a common occurrence, little is known with any certainty about the epidemiology of BPH (for which “prostatism” is a commonly, and wrongly, used synonym). Knowledge of risk factors is sparse: analytic epidemiologic studies of BPH are difficult to conduct. It is essential to establish an epidemiologic definition of BPH for these reasons. Both BPH and prostatism are the problems that seem set to increase in absolute terms. They are clearly identified as priority areas for research into their causes and treatment. However, it is clear that there is a great need for more epidemiologic information, particularly regarding prostatism, whose occurrence is unknown in many parts of the world.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Steg A
        Chronicle of achievements in the history of benign prostatic hyperplasia.
        Oxford Clinical Communications, Oxford1992
        • McNeal JE
        Monogr Urol. 1983; 4: 3-33
        • Isaacs JT
        • Coffey DS
        Etiology and disease process of benign prostatic hyperplasia.
        Prostate. 1989; 2: 35-50
        • Boyle P
        • McGinn R
        • Maisonneuve P
        • La Vecchia C
        Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed.
        Eur Urol. 1991; 20: 3-10
        • Berry SJ
        • Coffey DS
        • Walsh PC
        • Ewing LL
        The development of human benign prostatic hyperplasia with age.
        J Urol. 1984; 132: 474-479
      1. (1976)
        • Rotkin ID
        Epidemiology of benign prostatic hypertrophy: review and speculations.
        in: Grayhack JT Benign Prostatic Hyperplasia. Department of Health, Educations, and Welfare Publication no. (NIH) 76-1113, Government Printing Office, 1976: 105-117
        • Glynn RJ
        • Campion EW
        • Bouchard GR
        • Silbert JE
        The development of benign prostatic hyperplasia among volunteers in the Normative Ageing Study.
        Am J Epidemiol. 1985; 121: 78-90
        • Sidney S
        • Quesenberry Jr, CP
        • Sadler MC
        • Guess HA
        • Lydick EG
        • Cattolica EV
        Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan.
        Am J Epidemiol. 1991; 134: 825-829
        • Garraway WM
        • Collins GN
        • Lee RJ
        High prevalence of benign prostatic hypertrophy in the community.
        Lancet. 1991; 338: 469-471
        • Chute CG
        • Panser L
        • Girman CJ
        • Oesterling JE
        • Guess HA
        • Jacobsen SJ
        • Lieber MM
        The prevalence of prostatism: a population-based survey of urinary symptoms.
        J Urol. 1993; 150: 85-89
        • Arrighi HM
        • Guess HA
        • Metter EJ
        Symptoms and signs of prostatism as risk factors for prostatectomy.
        Prostate. 1990; 16: 253-261
        • Sagnier PP
        • Macfarlane G
        • Richard F
        • Botto H
        • Teillac P
        • Boyle P
        Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France.
        J Urol. 1994; 151: 1266-1270
        • Moon TD
        • Brannan W
        • Stone NN
        • Ercole C
        • Crawford ED
        • Chodak G
        • Brawer M
        • Heisey D
        • Bruskewitz RC
        Effect of age, educational status, ethnicity and geographic location on prostate symptom scores.
        J Urol. 1994; 152: 1498-1500
        • Guess HA
        Benign prostatic hyperplasia: antecedents and natural history.
        Epiddemiol Rev. 1992; 14: 131-153
        • Andersen GT
        • Nordling J
        • Walter S
        Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings.
        Scand J Urol Nephrol. 1979; 13: 229-236
        • The Department of Veteran Affairs Cooperative Study of Transurethral Resection for Benign Prostatic Hyperplasia
        A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia.
        J Urol. 1993; 150: 1696-1700
        • Wolfs GG
        • Knottnerus JA
        • Janknegt RA
        Prevalence and detection of micturition problems among 2,734 elderly men.
        J Urol. 1994; 152: 1467-1470
        • Garraway WM
        • Russel EB
        • Lee RJ
        • Collins GN
        • McKelvia GB
        • Hehir M
        • Rogers AC
        • Simpson RJ
        Impact of previously unrecognized benign prostatic hyperplasia on the lives of middle-aged and elderly men.
        Br J Gen Pract. 1993; 43: 318-321
        • Kirby R
        • Fitzpatrick J
        • Kirby M
        • Fitzpatrick A
        Shared care for prostatic diseases.
        Oxford ISIS Medical Media, Washington, DC1994
        • Brody JA
        Prospects for an ageing population.
        Nature. 1985; 315: 463-466
        • Roos NP
        • Malenka DJ
        • Fisher ES
        • McPherson K
        • Andersen TF
        • Cohen MM
        • Ramsey E
        Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.
        N Engl J Med. 1989; 320: 1120-1124
      2. Boyle P, Maisonneuve P and Steg A: Reduction in mortality from benign prostatic hyperplasia: a major unheralded health triumph. J Urol. (In press.)

        • World Health Organization
        Trends in prostate cancer 1980–1988.
        Wkly Epidemiol Rec. 1992; 67: 281-288